Anders M Greve

Summary

Publications

  1. doi request reprint Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study
    Anders M Greve
    Department of Medicine B, The Heart Center, Rigshospitalet, Copenhagen, Denmark
    Int J Cardiol 166:72-6. 2013
  2. doi request reprint Contrasting hemodynamic mechanisms of losartan- vs. atenolol-based antihypertensive treatment: a LIFE study
    Anders M Greve
    Department of Medicine B, The Heart Center, Rigshospitalet, Copenhagen, Denmark
    Am J Hypertens 25:1017-23. 2012
  3. doi request reprint Impact of QRS duration and morphology on the risk of sudden cardiac death in asymptomatic patients with aortic stenosis: the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study
    Anders M Greve
    Department of Medicine B, The Heart Center, Rigshospitalet, 9 Blegdamsvej, Copenhagen, Denmark
    J Am Coll Cardiol 59:1142-9. 2012
  4. doi request reprint Differences in cardiovascular risk profile between electrocardiographic hypertrophy versus strain in asymptomatic patients with aortic stenosis (from SEAS data)
    Anders M Greve
    Department of Medicine B, The Heart Center, Rigshospitalet, Copenhagen, Denmark
    Am J Cardiol 108:541-7. 2011
  5. doi request reprint Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study
    Anders M Greve
    Rigshospitalet, Department of Medicine B2142, The Heart Center, 9 Blegdamsvej, DK 2100, Copenhagen, Denmark
    Circulation 125:346-53. 2012
  6. doi request reprint Effect of lipid lowering on new-onset atrial fibrillation in patients with asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study
    Casper N Bang
    Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen, Denmark
    Am Heart J 163:690-6. 2012
  7. doi request reprint Left atrial size and function as predictors of new-onset of atrial fibrillation in patients with asymptomatic aortic stenosis: the simvastatin and ezetimibe in aortic stenosis study
    Casper N Bang
    Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen Denmark Electronic address
    Int J Cardiol 168:2322-7. 2013
  8. doi request reprint New-onset atrial fibrillation is associated with cardiovascular events leading to death in a first time myocardial infarction population of 89,703 patients with long-term follow-up: a nationwide study
    Casper N Bang
    Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen, Denmark
    J Am Heart Assoc 3:e000382. 2014
  9. doi request reprint The preventive effect of statin therapy on new-onset and recurrent atrial fibrillation in patients not undergoing invasive cardiac interventions: a systematic review and meta-analysis
    Casper N Bang
    Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen, Denmark
    Int J Cardiol 167:624-30. 2013
  10. doi request reprint Does lowering cholesterol have an impact on the progression of aortic stenosis?
    Anders M Greve
    Department of Medicine B, Rigshospitalet, The Heart Center, Copenhagen, Denmark
    Ther Adv Cardiovasc Dis 2:277-86. 2008

Detail Information

Publications10

  1. doi request reprint Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study
    Anders M Greve
    Department of Medicine B, The Heart Center, Rigshospitalet, Copenhagen, Denmark
    Int J Cardiol 166:72-6. 2013
    ..The frequency and prognostic importance of atrial fibrillation (AF) in asymptomatic mild-to-moderate aortic stenosis (AS) has not been well described...
  2. doi request reprint Contrasting hemodynamic mechanisms of losartan- vs. atenolol-based antihypertensive treatment: a LIFE study
    Anders M Greve
    Department of Medicine B, The Heart Center, Rigshospitalet, Copenhagen, Denmark
    Am J Hypertens 25:1017-23. 2012
    ..Pharmaceutical differences in central hemodynamics might influence cardiac response to antihypertensive treatment despite similar lowering of brachial blood pressure (BP)...
  3. doi request reprint Impact of QRS duration and morphology on the risk of sudden cardiac death in asymptomatic patients with aortic stenosis: the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study
    Anders M Greve
    Department of Medicine B, The Heart Center, Rigshospitalet, 9 Blegdamsvej, Copenhagen, Denmark
    J Am Coll Cardiol 59:1142-9. 2012
    ..The aim of the study was to examine the predictive value of QRS duration and morphology during watchful waiting in asymptomatic patients with aortic stenosis (AS)...
  4. doi request reprint Differences in cardiovascular risk profile between electrocardiographic hypertrophy versus strain in asymptomatic patients with aortic stenosis (from SEAS data)
    Anders M Greve
    Department of Medicine B, The Heart Center, Rigshospitalet, Copenhagen, Denmark
    Am J Cardiol 108:541-7. 2011
    ..Moreover, clinical covariates differ significantly between patients with electrocardiographic strain and those with LV hypertrophy by Sokolow-Lyon voltage criteria and Cornell voltage-duration criteria...
  5. doi request reprint Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study
    Anders M Greve
    Rigshospitalet, Department of Medicine B2142, The Heart Center, 9 Blegdamsvej, DK 2100, Copenhagen, Denmark
    Circulation 125:346-53. 2012
    ..The prognostic impact of ECG left ventricular strain and left ventricular hypertrophy (LVH) in asymptomatic aortic stenosis is not well described...
  6. doi request reprint Effect of lipid lowering on new-onset atrial fibrillation in patients with asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study
    Casper N Bang
    Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen, Denmark
    Am Heart J 163:690-6. 2012
    ..This effect has not been investigated on new-onset AF in asymptomatic patients with aortic stenosis (AS)...
  7. doi request reprint Left atrial size and function as predictors of new-onset of atrial fibrillation in patients with asymptomatic aortic stenosis: the simvastatin and ezetimibe in aortic stenosis study
    Casper N Bang
    Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen Denmark Electronic address
    Int J Cardiol 168:2322-7. 2013
    ..It remains unclear whether these variations in LA parameters can predict new-onset atrial fibrillation (AF) in asymptomatic patients with aortic stenosis (AS)...
  8. doi request reprint New-onset atrial fibrillation is associated with cardiovascular events leading to death in a first time myocardial infarction population of 89,703 patients with long-term follow-up: a nationwide study
    Casper N Bang
    Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen, Denmark
    J Am Heart Assoc 3:e000382. 2014
    ..However, previous studies have reported conflicting results and no data exist to explain the underlying cause of higher death rates in these patients...
  9. doi request reprint The preventive effect of statin therapy on new-onset and recurrent atrial fibrillation in patients not undergoing invasive cardiac interventions: a systematic review and meta-analysis
    Casper N Bang
    Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen, Denmark
    Int J Cardiol 167:624-30. 2013
    ..However, the current evidence on the benefit of statins unrelated to invasive cardiac interventions has not been clarified systematically...
  10. doi request reprint Does lowering cholesterol have an impact on the progression of aortic stenosis?
    Anders M Greve
    Department of Medicine B, Rigshospitalet, The Heart Center, Copenhagen, Denmark
    Ther Adv Cardiovasc Dis 2:277-86. 2008
    ..Finally, we review if computerized tomography, biomarkers, and clinical characteristics such as left ventricular ejection fraction, can be useful in stratifying patients to potential benefit of statin therapy...